stockpiles were capitalsed at a high cost and I think it caught the auditors attention in the annual report so kind of think that's where a lot of the cost came from .
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025